Drug Topics
JANUARY 30, 2023
Pfizer Inc. and Moderna Inc. have indicated that they are going to price their shots at between $110 and $130. The shots should still be free to individuals because of rules barring out-of-pocket costs for such vaccinations.
STAT
JANUARY 30, 2023
The federal government will audit Medicare Advantage insurers aggressively under a rule finalized Monday, which is expected to result in billions of dollars in overpayments going back toward Medicare’s trust fund and patients over the next decade. However, federal officials watered down one of the auditing policies by giving insurers seven years of immunity from having the samples of their diagnosis coding errors extrapolated to their broader Medicare Advantage membership.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 30, 2023
Sixteen states have banned a pharmacy benefit management practice that involves not counting the value of drug copay assistance from manufacturers toward patient deductibles.
STAT
JANUARY 30, 2023
The federal government and health insurance companies have been clashing for more than a decade over how Medicare Advantage plans should be audited and how the well-documented overpayments to those plans should be clawed back. That fight is about to hit an inflection point this week, when Medicare makes a final determination about how aggressively it will probe the industry.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JANUARY 30, 2023
Elacestrant, now with the brand name Orserdu, is an oral selective estrogen receptor degrader (SERD), which works by blocking the effects of estrogen on hormone receptor-positive breast cancer cells.
STAT
JANUARY 30, 2023
SAN FRANCISCO — “Why is it in popular culture, if you want to live forever, you are evil and you want to kill babies on the side?” says Martin Borch Jensen. It’s fast approaching 10 p.m. on the first night of the J.P. Morgan Healthcare Conference , and among a couple stragglers at a dinner for longevity CEOs, scientists, and investors, the conversation has turned from the practical or merely social to the philosophical.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JANUARY 30, 2023
In a victory for the pharmaceutical industry, a federal appeals court ruled drug companies have the right to limit discounts to hospitals that rely on numerous contract pharmacies as they participate in a U.S. government drug discount program. The decision was made in response to lawsuits that were originally filed by three large drugmakers — Sanofi, Novo Nordisk, and AstraZeneca — that the federal government was unlawfully interpreting key provisions in the controversial 340B drug
Fierce Healthcare
JANUARY 30, 2023
Industry Voices—5 steps to develop an effective 'always-on' patient communication strategy hlandi Mon, 01/30/2023 - 18:17
STAT
JANUARY 30, 2023
WASHINGTON — A Food and Drug Administration official on Monday gave more clues for how the agency plans to wield new authority to make drug companies enroll post-market clinical trials before granting speedy drug approvals. That new power is part of reforms to the FDA’s accelerated approval path that Congress recently passed. Accelerated approvals allow the agency to provide fast access to drugs for serious and life-threatening diseases by approving them based on test results
Fierce Healthcare
JANUARY 30, 2023
Medicare Advantage plans lose out in final RADV audit rule that ditches fee-for-service adjuster rking Mon, 01/30/2023 - 15:36
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JANUARY 30, 2023
This month marks the 40th anniversary of the Orphan Drug Act. Since it was signed into law in 1983, the FDA has approved more than 1,100 treatments for rare diseases. The act also created an industry that didn’t exist in the United States before its enactment, enabling the formation of companies to develop and commercialize therapies for rare diseases.
Drug Store News
JANUARY 30, 2023
Investments in pharmacy technology and innovation will be a key differentiator for U.S. drug stores wishing to gain an edge over the competition.
The Checkup by Singlecare
JANUARY 30, 2023
Your thyroid is a small, butterfly-shaped endocrine gland that sits on top of the trachea, near the bottom of the neck. The thyroid is like the gas pedal to your body: It’s responsible for bodily processes, including metabolism, growth, and brain development. When functioning normally, the thyroid releases a steady amount of thyroid hormones—triiodothyronine (T3) and thyroxine (T4)—into the bloodstream.
STAT
JANUARY 30, 2023
WASHINGTON — President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing Covid-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first declared. The move to end the national emergency and public health emergency declarations would formally restructure the federal coronavirus response to treat the virus as an endemic threat to public health that can be managed through agencies’ norm
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Luxe Pharmacist
JANUARY 30, 2023
As many of you know I’ve been on a bit of a health kick since the end of October, so I’m not necessarily creating new resolutions for 2023 when it comes to health. Instead, this year is about continuing my commitment to physical and mental wellness. As a whole this involves obviously many different aspects of my life and daily habits but today I wanted to talk about one area in particular, gut health.
STAT
JANUARY 30, 2023
The World Health Organization announced Monday that the Covid-19 pandemic remains a public health emergency, but signaled strongly that it believes it may be able to lift that designation in coming months. The decision to extend the pandemic’s status as a public health emergency of international concern, or PHEIC, was made on the advice of a committee of outside experts who met Friday to deliberate on the issue.
Drug Store News
JANUARY 30, 2023
The underlying growth rate will be driven by new drug launches and wider use of recently launched brands despite efforts by payers to constrain their budgets, and the impact of lower-cost options.
STAT
JANUARY 30, 2023
At every stage of the Covid-19 pandemic, national reporting of racial and ethnic disparities in Covid-19 testing, diagnosis, disease severity, treatment, and vaccination by clinicians, public health organizations, and the media has been marred by frustrating data deficiencies. How bad has the problem been? Far beyond bad.
Fierce Healthcare
JANUARY 30, 2023
Commonwealth Fund: US has lower life expectancy but spends most on health compared to other countries rking Mon, 01/30/2023 - 13:32
STAT
JANUARY 30, 2023
Several U.K. lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine, citing concerns such a move could strain the U.K. National Health Service and public finances. In a letter to Pfizer chief executive officer Albert Bourla, the lawmakers noted the company plans to raise the price of its shot to $110 to $130 a dose in the U.S. and they asked him to confirm during an upcoming call with Wall Street analysts and investors that Pfizer will not take the same step in the U.K.
Fierce Healthcare
JANUARY 30, 2023
White House plans to end COVID emergency declarations on May 11 hlandi Mon, 01/30/2023 - 22:10
STAT
JANUARY 30, 2023
Given everything he’s been through, Bobby Wiseman says he should have been dead instead of celebrating the birth of his first grandchild several days ago. Wiseman, 51, who lives near Sacramento, was diagnosed as an infant with hemophilia, the rare genetic disease that prevents blood from clotting. He tested positive for HIV and hepatitis C when he was 11 after catching the viruses from contaminated blood-clotting products.
Drug Store News
JANUARY 30, 2023
​​​​​​​Collaborations with Meharry Medical College, Sinai Chicago and Wayne State University will expand access to community health workers and care.
STAT
JANUARY 30, 2023
The Food and Drug Administration has installed Troy Tazbaz, most recently a senior vice president at Oracle, as its new head of digital health. Tazbaz will be the new director of the Digital Health Center of Excellence, according to an update to his LinkedIn profile Monday morning. He’ll take over for Brendan O’Leary, who has been acting director since February.
Drug Store News
JANUARY 30, 2023
Fast Twitch beverages contain 200 mg of caffeine and were developed in consultation with the NFL and sports performance experts, the company said.
STAT
JANUARY 30, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of online calls, meetings, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So we will try giving it a nudge in a better direction with a cup of stimulation.
Outsourcing Pharma
JANUARY 30, 2023
The UKâs House of Lords Science and Technology Committee reported the findings from an inquiry into the state of clinical research in the country.
European Pharmaceutical Review
JANUARY 30, 2023
Jaypirca (pirtobrutinib) has been approved by the US Food and Drug Administration (FDA), making it the first and only FDA-approved non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor. It is indicated for adults with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.
Drug Store News
JANUARY 30, 2023
4U by Tia, a new haircare brand founded by actress and entrepreneur Tia Mowry, is landing exclusively at Walmart.
PharmaVoice
JANUARY 30, 2023
Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights.
Outsourcing Pharma
JANUARY 30, 2023
The clinical trial was set up to investigate whether combining opioids with common psychotropic drugs would increase risk of respiratory depression.
Fierce Healthcare
JANUARY 30, 2023
Tech startup Paradigm lands $203M to get more patients into clinical research, accelerate drug trials hlandi Mon, 01/30/2023 - 11:51
Drug Store News
JANUARY 30, 2023
The new launches include Root Touch Up Color + Volume 2-in-1 Spray, Natural Instincts Bold and Blonde It Up Crystal Glow Toners.
Fierce Healthcare
JANUARY 30, 2023
Hospitals faced 'worst financial year since the start of the pandemic' in 2022, Kaufman Hall data show dmuoio Mon, 01/30/2023 - 14:44
Expert insights. Personalized for you.
200 
Let's personalize your content